NCT04936308 2026-03-12
SOLSTICE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT06641089 2026-03-11
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3 Recruiting
NCT03162796 2021-02-03
Discover-1
Janssen Research & Development, LLC
Phase 3 Completed
NCT01519089 2015-08-13
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Pfizer
Phase 3 Completed